216 results on '"Trifilio, Steven"'
Search Results
2. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem‐cell transplantation
3. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review
4. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death
5. Dose-intense etoposide–cyclophosphamide without stem cell transplantation for patients with intermediate and high cytogenetic risk primary refractory and relapsed acute myeloid leukemia
6. Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia
7. Changing Epidemiology of Clostridium difficile–Associated Disease during Stem Cell Transplantation
8. Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab
9. Questioning the Role of a Neutropenic Diet following Hematopoetic Stem Cell Transplantation
10. Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
11. Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
12. Filgrastim versus TBO-filgrastim to reduce the duration of neutropenia after autologous hematopoietic stem cell transplantation: TBO, or not TBO, that is the question
13. Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project
14. Update on Antifungal Drug Dosing and Therapeutic Drug Monitoring
15. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
16. Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique
17. Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation
18. Non-Steroid Anti-Inflammatory Drug Salsalate Provides Safe and Effective Pain Control during Stem Cell Transplantation
19. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
20. Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers
21. Long-term safety of filgrastim (rhG-CSF) administration: response to Confer & Miller and Bacher & Zander
22. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
23. The Research on Adverse Drug Events and Reports (RADAR) Project
24. Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation.
25. Tacrolimus Dose Adjustment for SCT Recipients Receiving Concommitant Isavuconazole
26. Revisiting Infectious Complications Following Total Parenteral Nutrition Use During Hematopoietic Stem Cell Transplantation.
27. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation
28. Leaving Them behind is Hard to Do—Impact of Facilities Change on Infection in a Stem Cell Transplant Unit
29. Revisiting Infectious Complications in Hematopoetic Stem Cell Transplantation Recipients Who Receive Total Parenteral Nutrition
30. Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation.
31. Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event
32. CDEA for Peripheral Blood Stem Cell Mobilization
33. Infectious Complications in Hematopoetic Stem Transplantation Recipients Who Receive Total Parenteral Nutrition
34. Tbo or Not Tbo-That Is the Question!
35. Economics of Malignant Gliomas: A Critical Review
36. 569 - Leaving Them behind is Hard to Do—Impact of Facilities Change on Infection in a Stem Cell Transplant Unit
37. Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies.
38. Amphotericin B Nasal Spray Appears Effective in Preventing Breakthrough Fungal Infections in Colonized SCT Recipients
39. Pancreatitis In Patients Treated With Brentuximab Vedotin: A Previously Unrecognized Serious Adverse Event
40. Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs
41. Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project
42. Polymicrobial and Multiple Microbiologically Proven Infections in HSCT Recipients
43. Idarubicin Appears Equivalent to Dose-Intense daunorubicin for AML Induction
44. Dose-Intense Etoposide and Cyclophosphamide without Stem Cell Transplantation for the Treatment of Primary Refractory and Relapsed Acute Myeloid Leukemia
45. Anaphylaxis Associated with Administration of Repeated Courses of Rasburicase: A Research On Adverse Drug Events and Reports (RADAR) Project
46. Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique
47. Novel risk factors for osteonecrosis of the jaw in multiple myeloma: A RADAR report.
48. Bisphosphonates and esophageal cancer: A RADAR report.
49. Administration of All-Trans Retinoic Acid (ATRA) to Newly Diagnosed Patients (pts) with Acute Promyelocytic Leukemia (APL) Is Delayed Even At Experienced Centers and Associated with An Increased Early Death Rate (EDR): A Retrospective Analysis of 205 Pts
50. Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.